This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02495/identifier/chemspider/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02495/identifier/bindingdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02495/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02495/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02495/identifier/pubchem-substance/
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02495/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02495
rdf:type
n3:Drug
n3:description
9-(4-hydroxybutyl)-N2-phenylguanine is a solid. This compound belongs to the hypoxanthines. These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine is known to target thymidine kinase.
n3:generalReferences
# Kaufman HE, Varnell ED, Wright GE, Xu H, Gebhardt BM, Thompson HW: Effect of 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, on clinical recurrences of ocular herpetic keratitis in squirrel monkeys. Antiviral Res. 1996 Dec;33(1):65-72. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8955854 # Gebhardt BM, Focher F, Eberle R, Manikowski A, Wright GE: Effect of combinations of antiviral drugs on herpes simplex encephalitis. Drug Des Devel Ther. 2009 Dec 29;3:289-94. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/20054446
n3:group
experimental
owl:sameAs
n7:DB02495 n13:DB02495
dcterms:title
9-(4-hydroxybutyl)-N2-phenylguanine
adms:identifier
n9:448110 n10:46507186 n11:DB02495 n12:BPG n14:21866 n15:395019
n3:synonym
HBPG
n3:IUPAC-Name
n4:271B6341-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6347-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6346-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6343-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6344-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6345-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B633F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B633D-363D-11E5-9242-09173F13E4C5 n4:271B6340-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B633E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B634D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B634E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B6348-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6349-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B634B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B634A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B634C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6353-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6355-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6356-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6352-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6351-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6354-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6342-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B634F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6350-363D-11E5-9242-09173F13E4C5